IDEXX LABORATORIES INC /DE Derivative Asset, Fair Value, Gross Asset
IDEXX LABORATORIES INC /DE (IDXX) had Derivative Asset, Fair Value, Gross Asset of $7.29 million as of 2014-09-30, per its 10-Q filed 2014-10-24.
Discontinued › Notes › Offsetting › Derivative Asset, Subject to Master Netting Arrangement, before Offset of Collateral
us-gaap:DerivativeFairValueOfDerivativeAsset · last filed 2014-10-24
- 2014-09-30: Derivative Asset, Fair Value, Gross Asset $7.29M.
- 2014-06-30: Derivative Asset, Fair Value, Gross Asset $1.32M.
- 2014-03-31: Derivative Asset, Fair Value, Gross Asset $3.01M.
- 2013-12-31: Derivative Asset, Fair Value, Gross Asset $4.04M.
| Period end | Derivative Asset, Fair Value, Gross Asset |
|---|---|
| 2014-09-30 | $7.29M 10-Q · filed 2014-10-24 |
| 2014-06-30 | $1.32M 10-Q · filed 2014-07-25 |
| 2014-03-31 | $3.01M 10-Q · filed 2014-04-25 |
| 2013-12-31 | $4.04M 10-Q · filed 2014-10-24 |
| 2013-03-31 | $5.34M 10-Q · filed 2013-04-23 |
| 2012-12-31 | $2.13M 10-Q · filed 2013-04-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lantheus Holdings, Inc. (LNTH) | United States | $6.510B | 26.31 |
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |